The Claim
Circulating lipopolysaccharide (LPS) and lipopolysaccharide-binding protein (LBP) are independently associated with an increased risk of carotid atherosclerosis and adverse cardiovascular events.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Higher levels of lipopolysaccharide and its binding protein in the blood are linked to a greater risk of plaque buildup in the carotid arteries and serious heart-related events.
See the scientific wording
Circulating lipopolysaccharide (LPS) and its binding protein (LBP) are independently associated with increased risk of carotid atherosclerosis and adverse cardiovascular events, suggesting that gut barrier dysfunction and microbial translocation contribute to systemic inflammation and vascular disease progression.
When the gut lining becomes damaged, bacteria and their toxins leak into the blood. These toxins bind to immune cells in the artery walls, turning on a persistent inflammatory response that damages the arteries, builds up plaque, and makes heart attacks and strokes more likely.
What the research says
1 studyWhen the gut barrier is damaged, bacterial toxins can leak into the blood and cause inflammation that harms arteries—this study shows that this exact process is linked to hardening of the arteries and heart problems.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.